[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
DOI
URL
|
[2] |
HUANG C H, LEI K F. Cell marathon:long-distance cell migration and metastasis-associated gene analysis using a folding paper system[J]. Lab Chip, 2022, 22(20):3827-3836.
DOI
URL
|
[3] |
KIM H S, EL-SERAG H B. The epidemiology of hepatocellular carcinoma in the USA[J]. Curr Gastroenterol Rep, 2019, 21(4):17.
DOI
|
[4] |
BOZKAYA Y, DEMIRCI N S, KURTIPEK A, et al. Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma[J]. Mol Clin Oncol, 2017, 7(2):267-274.
DOI
PMID
|
[5] |
AL-SAWAT A, BEA J H, HAN S R, et al. Use of ascitic CEA levels as a predictive value for distant metastasis in high-risk stage Ⅱ and Ⅲ colorectal cancer[J]. Int J Colorectal Dis, 2022, 37(2):365-372.
DOI
|
[6] |
NUMATA T, ENDO T, YANAI H, et al. Serum CEA and CYFRA levels in ALK-rearranged NSCLC patients:correlation with distant metastasis[J]. In Vivo, 2020, 34(4):2095-2100.
DOI
URL
|
[7] |
JIANG W, BAI W, LI J, et al. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer[J]. Int J Cancer, 2021, 148(4):1006-1013.
DOI
URL
|
[8] |
TONG J, JIANG W, ZHANG X, et al. CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma[J]. J Int Med Res, 2022, 50(12):3000605221139555.
|
[9] |
HUAI Q, LUO C Y, SONG P, et al. Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy[J]. Cancer sci, 2023, 114(12):4484-4498.
DOI
URL
|
[10] |
LIU H L, FENG X, TANG M M, et al. Prognostic significance of preoperative lymphocyte to monocyte ratio in patients with signet ring gastric cancer[J]. World J Gastrointest Surg, 2023, 15(8):1673-1683.
DOI
URL
|
[11] |
CHEN Y, SUN J, HU D, et al. Predictive value of pretreatment lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in the survival of nasopharyngeal carcinoma patients[J]. Cancer Manag Res, 2021,13:8767-8779.
|
[12] |
DE B, LUDMIR E B, MESSICK C A, et al. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma[J]. J Gastrointest Oncol, 2021, 12(5):2412-2422.
DOI
PMID
|
[13] |
ITO Y, ONODA N, KIHARA M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in differentiated thyroid carcinoma having distant metastasis:a comparison with thyroglobulin-doubling rate and tumor volume-doubling rate[J]. In Vivo, 2021, 35(2):1125-1132.
DOI
URL
|
[14] |
HUNG H C, LEE J C, WANG Y C, et al. Response prediction in immune checkpoint inhibitor immunotherapy for advanced hepatocellular carcinoma[J]. Cancers(Basel), 2021, 13(7):1607.
|
[15] |
ALBRENGUES J, SHIELDS M A, NG D, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice[J]. Science, 2018, 361(6409):eaao4227.
|
[16] |
BALKWILL F, MANTOVANI A. Inflammation and cancer:back to virchow?[J]. Lancet, 2001, 357(9255):539-545.
DOI
URL
|
[17] |
COFFELT S B, KERSTEN K, DOORNEBAL C W, et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis[J]. Nature, 2015, 522(7556):345-348.
DOI
|
[18] |
LOI S, SIRTAINE N, PIETTE F, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase Ⅲ randomized adjuvant breast cancer trial in node-positiveb breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy:BIG 02-98[J]. J Clin Oncol, 2013, 31(7):860-867.
DOI
URL
|
[19] |
KUMARI R, HOSSEINI E S, WARRINGTON K E, et al. Butyrophilins:dynamic regulators of protective T cell immunity in cancer[J]. Int J Mol Sci, 2023, 24(10):8722.
DOI
URL
|
[20] |
LI P, LI F, ZHANG Y, et al. Metabolic diversity of tumor-infiltrating T cells as target for anti-immune therapeutics[J]. Cancer Immunol Immunother, 2023, 72(11):3453-3460.
DOI
PMID
|
[21] |
WU Z, ZHENG Y, SHENG J, et al. CD3+CD4-CD8-(double-negative) T cells in inflammation,immune disorders and cancer[J]. Frontiers in Immunology, 2022,13:816005.
|
[22] |
RUDDELL A, HARRELL M I, FURUYA M, et al. B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma[J]. Neoplasia, 2011, 13(8):748-757.
DOI
PMID
|
[23] |
MAKITA K, HAMAMOTO Y, KANZAKI H, et al. An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy[J]. Thorac Cancer, 2023, 14(19):1795-1801.
DOI
URL
|
[24] |
ZHANG X, WANG X, LI W, et al. Predictive value of neutrophil-to-lymphocyte ratio for distant metastasis in gastric cancer patients[J]. Sci Rep, 2022, 12(1):10269.
DOI
PMID
|
[25] |
WIRA WIGUNA I G W, INDRANI REMITHA N P S, SADVIKA I G A S, et al. Pretreatment leukocyte count ratios as metastatic predictive factors in luminal type breast cancer[J]. Asian Pac J Cancer Prev, 2022, 23(5):1595-1601.
DOI
URL
|